Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

被引：0
|
作者：
Julia Stockmann
Inge M. W. Verberk
Nina Timmesfeld
Robin Denz
Brian Budde
Julia Lange-Leifhelm
Philip Scheltens
Wiesje M. van der Flier
Andreas Nabers
Charlotte E. Teunissen
Klaus Gerwert
机构：
[1] Ruhr-University Bochum,Competence Center for Biospectroscopy, Center for Protein Diagnostics (PRODI)
[2] Ruhr University Bochum,Department of Biophysics, Faculty of Biology and Biotechnology
[3] Vrije Universiteit Amsterdam,Department of Clinical Chemistry, Neurochemistry Laboratory, Amsterdam Neuroscience
[4] Amsterdam UMC,Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience
[5] Vrije Universiteit Amsterdam,Department of Medical Informatics, Biometry and Epidemiology
[6] Amsterdam UMC,undefined
[7] Ruhr University Bochum,undefined
来源：
Alzheimer's Research & Therapy | / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
相关论文
共 50 条
  • [11] Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
    Lui, James K.
    Laws, Simon M.
    Li, Qiao-Xin
    Villemagne, Victor L.
    Ames, David
    Brown, Belinda
    Bush, Ashley I.
    De Ruyck, Karl
    Dromey, Jasmin
    Ellis, Kathryn A.
    Faux, Noel G.
    Foster, Jonathan
    Fowler, Christopher
    Gupta, Veer
    Hudson, Peter
    Laughton, Katrina
    Masters, Colin L.
    Pertile, Kelly
    Rembach, Alan
    Rimajova, Mira
    Rodrigues, Mark
    Rowe, Christopher C.
    Rumble, Rebecca
    Szoeke, Cassandra
    Taddei, Kevin
    Taddei, Tania
    Trounson, Brett
    Ward, Vanessa
    Martins, Ralph N.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) : 1233 - 1242
  • [12] Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment
    Giacomucci, Giulia
    Mazzeo, Salvatore
    Bagnoli, Silvia
    Ingannato, Assunta
    Leccese, Deborah
    Berti, Valentina
    Padiglioni, Sonia
    Galdo, Giulia
    Ferrari, Camilla
    Sorbi, Sandro
    Bessi, Valentina
    Nacmias, Benedetta
    JOURNAL OF NEUROLOGY, 2022, 269 (08) : 4270 - 4280
  • [13] Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
    Giulia Giacomucci
    Salvatore Mazzeo
    Silvia Bagnoli
    Assunta Ingannato
    Deborah Leccese
    Valentina Berti
    Sonia Padiglioni
    Giulia Galdo
    Camilla Ferrari
    Sandro Sorbi
    Valentina Bessi
    Benedetta Nacmias
    Journal of Neurology, 2022, 269 : 4270 - 4280
  • [14] Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
    Pyun, Jung-Min
    Youn, Young Chul
    Park, Young Ho
    Kim, SangYun
    FRONTIERS IN NEUROLOGY, 2023, 13
  • [15] Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer's Disease
    Strikwerda-Brown, Cherie
    Ozlen, Hazal
    Binette, Alexa Pichet
    Chapleau, Marianne
    Marchant, Natalie L.
    Breitner, John C. S.
    Villeneuve, S.
    BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2023, 3 (01): : 130 - 138
  • [16] Quantification of baseline amyloid load in individuals with subjective cognitive decline can identify future risk of amyloid accumulation
    Kolinger, G.
    Marquie, M.
    Sotolongo-Grau, O.
    Roe-Vellve, N.
    Perez-Martinez, E.
    Koglin, N.
    Stephens, A.
    Tartari, J.
    Sanabria, A.
    Garcia-Sanchez, A.
    Tarraga, L.
    Ruiz, A.
    Bullich, S.
    Boada, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S48 - S48
  • [17] Amyloid-β Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
    Santos, Alexander Navarrete
    Ewers, Michael
    Minthon, Lennart
    Simm, Andreas
    Silber, Rolf-Edgar
    Blennow, Kaj
    Prvulovic, David
    Hansson, Oskar
    Hampel, Harald
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (01) : 171 - 176
  • [18] Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline
    Azargoonjahromi, Ali
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024, 76 (09) : 1115 - 1131
  • [19] Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline
    Reddy, P. Hemachandra
    Manczak, Maria
    Mao, Peizhong
    Calkins, Marcus J.
    Reddy, Arubala P.
    Shirendeb, Ulziibat
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S499 - S512
  • [20] Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study
    Chouraki, Vincent
    Beiser, Alexa
    Younkin, Linda
    Preis, Sarah Rosner
    Weinstein, Galit
    Hansson, Oskar
    Skoog, Ingmar
    Lambert, Jean-Charles
    Au, Rhoda
    Launer, Lenore
    Wolf, Philip A.
    Younkin, Steven
    Seshadri, Sudha
    ALZHEIMERS & DEMENTIA, 2015, 11 (03) : 249 - 257
12345